Notable company events
Since our presentation yesterday at the 2013 American Society of Human Genetics meeting, we have received several requests for information about our ab initio single copy FISH probes. These FISH probes are only available from Cytognomix and are the only products that can be used to detect differential accessibility in metaphase chromosomes. No other company makes these or equivalent FISH products.
Contact:
info@cytognomix.com or
info@scprobe.info
US Patent 8,209,129 has issued on single copy DNA probes which include divergent repetitive sequences, thus significantly extending the portions of the genome that can be used for such probes beyond traditional single copy sequences.
The technology also increases the density of genomic DNA probes for higher resolution genetic analysis beyond what is used in FISH, genomic microarrays for array comparative genomic hybridization, and solution capture hybrdization arrays for sequence enrichment in deep sequencing. It is licensed to Cytognomix.
Cytognomix’s new software product, the Shannon pipeline for human splicing mutation analysis of NGS sequencing data was presented at the BioIT World Conference and Expo (Apr 24-26, 2012), Boston.
Dr. Rogan describes our poster:
Large scale interpretation and stratification of non-coding sequence variants in the human genome. Ben Shirley1,Eliseos Mucaki2, & Peter Rogan1,2,3. Depts of Computer Science1 and Biochemistry2, and Cytognomix Inc3, London ON, Canada.
Cytognomix receives US Patent 7,734,424 entitled “AB INITIO GENERATION OF SINGLE COPY GENOMIC PROBES.”
Ontario Centre of Excellence for Commercialization of Research assists Cytognomix in building capacity through its Embedded Executive Program.
/
Canadian Institute for Photonic Innovations awards grant to the University of Western Ontario and Cytognomix through their Technology Exploitation and Networking Program.
MaRS Ventures Inc. (Toronto) accepts Cytognomix as a client of the Business Mentorship Entrepreneurship Program.
Cytognomix becomes a client of the NRC-IRAP program and receives an initial investment to create jobs in Ontario.